017-I — Autologous Level I - Phepheral Blood Stem Cell Transplant
Cite this view
HANK Price Transparency. (n.d.). Autologous Level I - Phepheral Blood Stem Cell Transplant (MS_DRG 017-I) negotiated rates. PPMan price-transparency data, derived from CMS-required hospital MRFs. Retrieved , from http://ppman.hank.ai/transparency/code/017-I?code_type=MS_DRG
“Autologous Level I - Phepheral Blood Stem Cell Transplant (MS_DRG 017-I) negotiated rates.” HANK Price Transparency, http://ppman.hank.ai/transparency/code/017-I?code_type=MS_DRG. Accessed .
“Autologous Level I - Phepheral Blood Stem Cell Transplant (MS_DRG 017-I) negotiated rates,” HANK Price Transparency, accessed , http://ppman.hank.ai/transparency/code/017-I?code_type=MS_DRG.
Source: PPMan price-transparency data, derived from CMS-required hospital machine-readable files (45 CFR 180). See methodology.
Usually $227,703–$227,703 (25th–75th percentile) across 1 hospital · 1 payer.
“Negotiated” is the hospital’s negotiated facility rate for this MS_DRG 017-I — the consumer-grade median across the country. It covers the facility charge only; the surgeon’s and anesthesiologist’s fees are billed separately.
Per-month price trends are temporarily unavailable while we rebuild them on quality-filtered rates. The medians, percentiles, and per-hospital rates on this page are the quality-filtered figures.
Hospital rates (per row)
Showing consumer-grade rates only. Flagged / outlier filings (excluded from the medians above) are hidden — tick “Show flagged / outlier rates” to include them.
| Hospital | Payer | Plan | Negotiated rate | Gross | Cash | Observed | Source |
|---|---|---|---|---|---|---|---|
| Hackensack University Medical Center InpatientFacility | QUALCARE | HMO | $227,703.00 | — | — | 2025-12-31 | MRF ↗ |
| Hackensack University Medical Center InpatientFacility | QUALCARE | PPO | $227,703.00 | — | — | 2025-12-31 | MRF ↗ |
| Hackensack University Medical Center InpatientFacility | QUALCARE | WORKERS COMP | $227,703.00 | — | — | 2025-12-31 | MRF ↗ |